BiotechTube
Home/TopAlliance Biosciences/Sheng Yao, Ph.D.
SY

Sheng Yao, Ph.D.

Chief Executive Officer and Executive Director

TopAlliance Biosciences

Therapeutic Areas

Oncology

TopAlliance Biosciences Pipeline

DrugIndicationPhase
LOQTORZI (Toripalimab)Nasopharyngeal Carcinoma (and other undisclosed oncology indications)Approved
Undisclosed ADC ProgramsOncologyNot Disclosed

Leadership Team at TopAlliance Biosciences

NL
Ning Li, M.D., Ph.D.
Chairman of the Board
PK
Patricia Keegan, M.D.
Chief Medical Officer
KL
Kevin Li, Ph.D.
Vice President of Regulatory Affairs
MH
Monica Hughes
Vice President of Project and Portfolio Management
View full TopAlliance Biosciences profile